{"id":5902,"date":"2025-05-22T04:11:53","date_gmt":"2025-05-22T04:11:53","guid":{"rendered":"https:\/\/medical-article.com\/?p=5902"},"modified":"2025-05-22T04:11:53","modified_gmt":"2025-05-22T04:11:53","slug":"pfizer-pledges-1-25b-for-drug-candidate-in-promising-but-competitive-area-of-immunotherapy","status":"publish","type":"post","link":"https:\/\/medical-article.com\/?p=5902","title":{"rendered":"Pfizer Pledges $1.25B for Drug Candidate in Promising But Competitive Area of Immunotherapy"},"content":{"rendered":"<p><a href=\"https:\/\/medcitynews.com\/2025\/05\/pfizer-bispecific-antibody-pd1-vegf-3sbio-cancer-immunotherapy\/\"><\/a><\/p>\n<p>Pfizer is in-licensing a bispecific antibody drug for cancer that China-based 3SBio designed to block the proteins PD-1 and VEGF. The deal puts the pharmaceutical giant in a growing group of companies developing bispecific antibodies for those targets, many of them with molecules originally developed in China. <\/p>\n<p>The post <a href=\"https:\/\/medcitynews.com\/2025\/05\/pfizer-bispecific-antibody-pd1-vegf-3sbio-cancer-immunotherapy\/\">Pfizer Pledges $1.25B for Drug Candidate in Promising But Competitive Area of Immunotherapy<\/a> appeared first on <a href=\"https:\/\/medcitynews.com\/\">MedCity News<\/a>.<\/p>","protected":false},"excerpt":{"rendered":"<p>Pfizer is in-licensing a bispecific antibody drug for cancer that China-based 3SBio designed to block the proteins PD-1 and VEGF. The deal puts the pharmaceutical giant in a growing group of companies developing bispecific antibodies for those targets, many of them with molecules originally developed in China. The post Pfizer Pledges $1.25B for Drug Candidate&#8230;<\/p>\n","protected":false},"author":0,"featured_media":5903,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[],"class_list":["post-5902","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-medicine"],"_links":{"self":[{"href":"https:\/\/medical-article.com\/index.php?rest_route=\/wp\/v2\/posts\/5902"}],"collection":[{"href":"https:\/\/medical-article.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medical-article.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/medical-article.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=5902"}],"version-history":[{"count":0,"href":"https:\/\/medical-article.com\/index.php?rest_route=\/wp\/v2\/posts\/5902\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medical-article.com\/index.php?rest_route=\/wp\/v2\/media\/5903"}],"wp:attachment":[{"href":"https:\/\/medical-article.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=5902"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medical-article.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=5902"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medical-article.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=5902"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}